Try our Advanced Search for more refined results
October 18, 2013
BAXTER HEALTHCARE CORPORATION et al v. HQ SPECIALTY PHARMA CORPORATION
Case Number:
2:13-cv-06228
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 22, 2013
Baxter Says Generic Co. Infringed Hypertension Med Patent
Baxter International Inc. on Tuesday hit HQ Specialty Pharma Corp. with a lawsuit in New Jersey federal court alleging HQ's proposed generic version of its blood pressure and heart rhythm disorder drug Brevibloc infringes two of its patents.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login